Publication Name	World Journal of Gastroenterology
Manuscript ID	6948
Country	Italy

Received	2013-10-30 20:05
Peer-Review Started	2013-11-01 10:04
To Make the First Decision	2013-12-04 09:17
Return for Revision	2013-12-05 20:17
Revised
Second Decision	2014-03-13 13:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-03-13 16:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-04-22 09:11
Publish the Manuscript Online	2014-05-07 10:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Anti-TNF alpha in the treatment of ulcerative colitis: A valid approach for organ-sparing or an expensive option to delay surgery?
Manuscript Source	Invited Manuscript
All Author List	Gianluca Rizzo, Daniela Pugliese, Alessandro Armuzzi and Claudio Coco
Funding Agency and Grant Number
Corresponding Author	Gianluca Rizzo, MD, Department of Surgical Sciences, Complesso Integrato Columbus, Catholic University of the Sacred Heart, Via F. Moscati 31-33, 00168 Rome, Italy. gianluca.rizzo1979@libero.it
Key Words	Ulcerative colitis; Infliximab; Colectomy; Post-operative complications; Cost-effectiveness; Inflammatory bowel disease
Core Tip	The introduction of biologic therapy with Infliximab (IFX) has significantly modified the clinical course of ulcerative colitis. In this study we systematically analyzed the role of IFX in reducing the colectomy rate, the risk of post-operative morbidity in pre-operatively IFX-treated patients and the cost-effectiveness of IFX therapy.
Publish Date	2014-05-07 10:10
Citation	Rizzo G, Pugliese D, Armuzzi A , Coco C. Anti-TNF alpha in the treatment of ulcerative colitis: A valid approach for organ-sparing or an expensive option to delay surgery? World J Gastroenterol 2014; 20(17): 4839-4845
URL	http://www.wjgnet.com/1007-9327/full/v20/i17/4839.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i17.4839

Full Article (PDF)	WJG-20-4839.pdf
Full Article (Word)	WJG-20-4839.doc
Manuscript File	6948-Review.doc
Answering Reviewers	6948-Answering reviewers.pdf
Copyright License Agreement	6948-Copyright assignment.pdf
Peer-review Report	6948-Peer reviewer(s).pdf
Scientific Editor Work List	6948-Scientific editor work list.doc